Search the Newsreel

CLVT|Clarivate PLC|Price:1.923|Chg%:-0.037

This article provides a detailed overview of Clarivate PLC (CLVT) stock, including its current price, market capitalization, key financial figures, and recent performance. It also covers analyst ratings, a technical analysis summary, company profile, and major shareholders. The stock's current rating is "Hold" with …

Claritev (CTEV) Q2 2026 Earnings Call Transcript

Clarus Corporation (NASDAQ:CLAR) Given Consensus Recommendation of "Hold" by Brokerages

Clarus Corporation (NASDAQ:CLAR) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $4.06. The company recently exceeded quarterly expectations, reporting $0.18 EPS against an estimated loss of $0.07, and revenue of $56.16 million, surpassing the $51.54 million …

Sei Investments Co. Makes New Investment in Aclaris Therapeutics, Inc. $ACRS

Jim Cramer Said Kimberly-Clark Corporation (NYSE:KMB) + Kenvue Could Take On P&G – But Is He Right?

Personal care products provider Kimberly-Clark Corporation (NYSE:KMB)'s shares are down by 17% over the past year and are up by 9% year-to-date. It is currently undergoing a major transformation through acquiring Kenvue. Cramer has discussed Kimberly-Clark Corporation (NYSE:KMB)'s acquisition several times and linked its …

ETFs Investing in Clarivate PLC Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Clarivate PLC (16A) stocks, providing investors with options to invest in the company indirectly. Each ETF entry includes details such as market value, weight of Clarivate PLC in the fund, issuer, management style, focus, …

Assenagon Asset Management S.A. Sells 163,661 Shares of Kimberly-Clark Corporation $KMB

Assenagon Asset Management S.A. significantly reduced its stake in Kimberly-Clark Corporation (NASDAQ:KMB) by 90% in the second quarter, selling 163,661 shares and retaining 18,228 shares worth approximately $2.0 million. This move comes as Kimberly-Clark reported mixed financial results, missing analyst consensus for EPS and …

Dimensional Fund Advisors LP Has $1.91 Million Stock Position in Aclaris Therapeutics, Inc. $ACRS

Dimensional Fund Advisors LP significantly increased its stake in Aclaris Therapeutics, Inc. by 88.8% in the first quarter, now holding 511,461 shares valued at approximately $1.91 million. This move is part of a broader trend of institutional investment, with such entities owning 98.34% of …

Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks

Clarke Inc Q2 Results: Net income turns positive at $50.5 million

Canada's Clarke Inc posts Q2 net income, driven by Ravelin acquisition

Clarke Inc. Reports 2026 Second Quarter Results

Clarus (CLAR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5 p.m. ET CALL PARTICIPANTS Executive Chairman - Warren KandersCFO - Mike YatesPresident of Black Diamond Equipment - Neil FiskeExternal Director of Investor Relations - Matt Berkowitz TAKEAWAYS Consolidated Sales -- $56.2 million, …

Kimberly Clark (KMB) Could Be 7% Below Fair Value After 2026 Outlook Cut

Kimberly-Clark (KMB) has reduced its 2026 outlook due to market disruptions in China, softer category trends, and North American shipment volatility. Despite these challenges, the company's strong brand equity and innovation pipeline are expected to drive sustainable EPS growth, leading to a fair value …

Kimberly-Clark secures $45M tariff refund, half of what it paid in 2026

Kimberly-Clark received a $45 million tariff refund in Q2 2026, which is approximately half of what it paid in North American tariffs last year. The company plans to use these funds to offset $150 million in gross input costs from rising oil prices in …

Does Clarivate’s Expanded Agentic AI Across Cortellis Reshape the Bull Case For Clarivate (CLVT)?

Clarivate Plc has expanded agentic AI capabilities across its Cortellis life sciences portfolio, aiming to integrate AI into drug discovery, safety assessment, and portfolio decision workflows. This move seeks to reduce manual effort and support faster, evidence-based decisions, reinforcing Clarivate's investment narrative around workflow …

Kimberly-Clark Names Suzana Blades General Counsel Ahead of Kenvue Deal

Kimberly-Clark Corporation has appointed Suzana Blades as senior vice president and general counsel, effective September 1, 2026. This promotion comes as the company prepares for its acquisition of Kenvue Inc. and a broader transformation of its health and wellness portfolio, placing Blades at the …

Kimberly-Clark appoints Suzana Blades as senior vice president and general counsel

Kimberly-Clark has appointed Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will also join the leadership team for Kimberly-Clark's pending acquisition of Kenvue Inc. Blades has been with Kimberly-Clark for nearly four years, previously serving as Vice President …

Kimberly-Clark names Suzana Blades as general counsel

Kimberly-Clark Corporation has announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades, who currently serves as Vice President & Deputy General Counsel at Kimberly-Clark, will also join the company’s Executive Leadership Team and the leadership …

Kimberly-Clark names Suzana Blades as general counsel By Investing.com

Kimberly-Clark Corporation announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. Blades will report to Jeff Melucci and join the company's Executive Leadership Team, and will also be part of the leadership team following Kimberly-Clark's acquisition …

Here's Why We're Wary Of Buying Clarus' (NASDAQ:CLAR) For Its Upcoming Dividend

Is Clarivate (CLVT) Below Fair Value On Its Cortellis Agentic AI Expansion?

Clarivate (CLVT) has expanded its Cortellis portfolio with new agentic AI capabilities aimed at accelerating life sciences R&D, despite its stock experiencing a significant decline. The company's valuation narrative suggests it is undervalued at $2.50 per share compared to its current price of $1.91, …

Clarivate : and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes

Clarivate and KYBORA have partnered to offer integrated, end-to-end transaction advisory services for bioph

Die Kimberly-Clark-Aktie reagiert auf durchwachsene Quartalszahlen und vorsichtige 2026er-Prognose

HC Wainwright Has Pessimistic Outlook of ACRS Q3 Earnings

Canvas Wealth Advisors LLC Purchases 28,291 Shares of Kimberly-Clark Corporation $KMB

Canvas Wealth Advisors LLC significantly increased its holdings in Kimberly-Clark Corporation (NASDAQ:KMB) by 186.5% in the second quarter, purchasing an additional 28,291 shares. This makes Kimberly-Clark its 29th biggest holding, valued at $4.82 million. The article also details recent analyst ratings, financial performance, and …

The 5 Most Interesting Analyst Questions From Clarus’s Q2 Earnings Call

Kimberly-Clark Corporation (NASDAQ:KMB) Given Average Recommendation of "Hold" by Brokerages

Kimberly-Clark Corporation (NASDAQ:KMB) has received an average "Hold" recommendation from brokerages, with an average 12-month price target of $117.93, compared to its current share price of $108.57. The company recently reported adjusted EPS of $1.80, missing consensus estimates, but announced a quarterly dividend of …

Black Diamond’s Apparel Streak Hits Five Quarters; DOJ Closes Clarus Investigation

Black Diamond, the anchor of Clarus Corp.'s Outdoor segment, reported an 8.5% sales increase in Q2, marking its fifth consecutive quarter of apparel growth. This positive financial news comes as the Department of Justice closed its criminal investigation into Black Diamond and two former …

Clarivate (NYSE:CLVT) Shares Gap Up on Insider Buying Activity

Clarivate (NYSE:CLVT) shares gapped up after Director Kenneth L. Cornick purchased 900,000 shares across two transactions totaling approximately $1.67 million. This insider buying activity occurred despite cautious analyst sentiment, with a consensus "Reduce" rating and a price target of $3.02. The company slightly exceeded …

CLAR Maintained by Roth Capital -- Price Target Raised to $3.75

Roth Capital has maintained a Neutral rating on Clarus Corporation (CLAR) but raised its price target to $3.75, an increase of 29.31%. Despite a slight undervaluation according to GF Value™ at $3.86 versus its current price of $3.82, the company's unprofitability and negative cash …

Kimberly-Clark Corporation (KMB) latest stock news and headlines

This Yahoo Finance page provides a compilation of recent news and headlines concerning Kimberly-Clark Corporation (KMB). It highlights the company's Q2 2026 earnings, including a focus on China risk and a lowered 2026 outlook, as well as announcements regarding a cash dividend and an …

Clarivate PLC (16A.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst ratings and price targets for Clarivate PLC (16A.MU). It lists recent "Upgrades & Downgrades" showing various firms maintaining their ratings, including Citigroup, Goldman Sachs, Stifel, and Barclays, with the latest update on July 30, 2026. The stock's current price is …